Myriad Genetics Inc
XETRA:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XETRA:MYD
|
US |
|
F
|
Five Below Inc
F:6F1
|
US |
|
T
|
TUI AG
XETRA:TUI1
|
DE |
|
Starwood Property Trust Inc
NYSE:STWD
|
US |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
Resona Holdings Inc
TSE:8308
|
JP |
|
I
|
Innovative Industrial Properties Inc
LSE:0JBD
|
US |
|
H
|
Hain Celestial Group Inc
SWB:HF1
|
US |
|
AT&T Inc
NYSE:T
|
US |
|
Coloplast A/S
CSE:COLO B
|
DK |
|
Hindustan Aeronautics Ltd
BSE:541154
|
IN |
|
Mitsui Chemicals Inc
TSE:4183
|
JP |
|
Eicher Motors Ltd
NSE:EICHERMOT
|
IN |
|
Abercrombie & Fitch Co
NYSE:ANF
|
US |
|
B
|
BYD Co Ltd
XBER:BY6
|
CN |
|
Vaxart Inc
F:NB11
|
US |
|
H
|
Horizon Construction Development Ltd
HKEX:9930
|
CN |
|
B
|
Bayer AG
BET:BAYER
|
DE |
|
K
|
Komercni Banka as
SWB:KONN
|
CZ |
|
Kilroy Realty Corp
NYSE:KRC
|
US |
|
K
|
Kawasaki Kisen Kaisha Ltd
F:KLI1
|
JP |
|
Swatch Group AG
LSE:0QJV
|
CH |
|
T
|
TUI AG
SWB:TUI1
|
DE |
|
Franco-Nevada Corp
TSX:FNV
|
CA |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
502.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
465B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 120.3m USD. This includes both short-term (0 USD) and long-term (120.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
